These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21103980)

  • 1. Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study.
    Nelson TL; Kamineni A; Psaty B; Cushman M; Jenny NS; Hokanson J; Furberg C; Mukamal KJ
    Diabetologia; 2011 Feb; 54(2):329-33. PubMed ID: 21103980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.
    Nelson TL; Biggs ML; Kizer JR; Cushman M; Hokanson JE; Furberg CD; Mukamal KJ
    J Clin Endocrinol Metab; 2012 May; 97(5):1695-701. PubMed ID: 22399516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study.
    Jenny NS; Solomon C; Cushman M; Tracy RP; Nelson JJ; Psaty BM; Furberg CD
    Atherosclerosis; 2010 Apr; 209(2):528-32. PubMed ID: 19804884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
    Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
    Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A₂ activity predicts progression of subclinical coronary atherosclerosis.
    Kinney GL; Snell-Bergeon JK; Maahs DM; Eckel RH; Ehrlich J; Rewers M; Hokanson JE
    Diabetes Technol Ther; 2011 Mar; 13(3):381-7. PubMed ID: 21291330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes.
    Hatoum IJ; Hu FB; Nelson JJ; Rimm EB
    Diabetes; 2010 May; 59(5):1239-43. PubMed ID: 20185811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.
    Furberg CD; Nelson JJ; Solomon C; Cushman M; Jenny NS; Psaty BM
    J Am Geriatr Soc; 2008 May; 56(5):792-9. PubMed ID: 18363676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.
    Suzuki T; Solomon C; Jenny NS; Tracy R; Nelson JJ; Psaty BM; Furberg C; Cushman M
    Circ Heart Fail; 2009 Sep; 2(5):429-36. PubMed ID: 19808373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.
    Onat A; Hergenç G; Can G; Uğur M; Nartop F
    Clin Chem Lab Med; 2011 Aug; 49(8):1349-1357. PubMed ID: 21756164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.
    Ridker PM; MacFadyen JG; Wolfert RL; Koenig W
    Clin Chem; 2012 May; 58(5):877-86. PubMed ID: 22419750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.
    Noto H; Chitkara P; Raskin P
    J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients.
    Allison MA; Denenberg JO; Nelson JJ; Natarajan L; Criqui MH
    J Vasc Surg; 2007 Sep; 46(3):500-6. PubMed ID: 17681710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
    Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
    Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature.
    Gregson J; Stirnadel-Farrant HA; Doobaree IU; Koro C
    Atherosclerosis; 2012 Nov; 225(1):11-21. PubMed ID: 22784637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
    Heart Protection Study Collaborative Group
    J Intern Med; 2010 Oct; 268(4):348-58. PubMed ID: 21050287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A(2): a promising vascular-specific marker for screening cardiovascular risk?
    Lee JH; Engler MM
    Prog Cardiovasc Nurs; 2009 Dec; 24(4):181-9. PubMed ID: 20002343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
    Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
    J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors].
    Jia ZR; Zhao D; Qi Y; Wang W; Wang M; Sun JY; Qin LP; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):962-7. PubMed ID: 24370228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes.
    Constantinides A; van Pelt LJ; van Leeuwen JJ; de Vries R; Tio RA; van der Horst IC; Sluiter WJ; Dullaart RP
    Eur J Clin Invest; 2011 Aug; 41(8):820-7. PubMed ID: 21281278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.